{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T22:07:07Z","timestamp":1766182027377,"version":"3.40.5"},"reference-count":39,"publisher":"Galenos Yayinevi","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjo"],"published-print":{"date-parts":[[2022,12,1]]},"DOI":"10.4274\/tjo.galenos.2022.50945","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T12:38:53Z","timestamp":1672231133000},"page":"366-373","source":"Crossref","is-referenced-by-count":3,"title":["Age-Related Differences in the Clinical Patterns of Ocular Graft-Versus-Host Disease"],"prefix":"10.4274","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9139-8848","authenticated-orcid":false,"given":"Rana","family":"Altan-Yayc\u0131o\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0177-9517","authenticated-orcid":false,"given":"Yonca","family":"Ayd\u0131n Akova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2937-1521","authenticated-orcid":false,"given":"Oya","family":"D\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem cell transplantation","volume":"354","author":"Copelan","year":"2006","unstructured":"1. Copelan EA. Hematopoietic stem cell transplantation. N Engl J Med. 2006;354:1813-1826.","journal-title":"N Engl J Med"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/ACI.0b013e328357b4b9","article-title":"Ocular graft-versus-host disease","volume":"12","author":"Hessen","year":"2012","unstructured":"2. Hessen M, Akpek EK. Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol. 2012;12:540-547.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","unstructured":"3. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz K, Shulman H, Turner M, Vogelsang G, Flowers ME. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945-956.","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/01.icu.0000233952.09595.d8","article-title":"Update on ocular graft versus host disease","volume":"17","author":"Kim","year":"2006","unstructured":"4. Kim SK. Update on ocular graft versus host disease. Curr Opin Ophthalmol. 2006; 17:344-348.","journal-title":"Curr Opin Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/ICO.0000000000000340","article-title":"Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation","volume":"34","author":"Shikari","year":"2015","unstructured":"5. Shikari H, Amparo F, Saboo U, Dana R. Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation. Cornea. 2015;34:243-247.","journal-title":"Cornea"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Fall-Dickson JM, Pavletic SZ, Mays JW, Schubert MM. Oral complications of chronic graft-versus-host disease. J Natl Cancer Inst Monogr. 2019;2019:lgz007.","DOI":"10.1093\/jncimonographs\/lgz007"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1136\/bjophthalmol-2017-311529","article-title":"Statistical approaches in published ophthalmic clinical science papers: a comparison to statistical practice two decades ago","volume":"102","author":"HG","year":"2018","unstructured":"7. Zhang HG, Ying GS. Statistical approaches in published ophthalmic clinical science papers: a comparison to statistical practice two decades ago. Br J Ophthalmol. 2018;102:1188-1191.","journal-title":"Br J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1038\/srep03419","article-title":"International chronic ocular graft-versus-host disease (GVHD) consensus group: proposed diagnostic criteria for chronic GVHD (part I)","volume":"3","author":"Ogawa","year":"2013","unstructured":"8. Ogawa Y, Kim SK, Dana R, Clayton J, Jain S, Rosenblatt MI, Perez VL, Shikari H, Riemens A, Tsubota K. International chronic ocular graft-versus-host disease (GVHD) consensus group: proposed diagnostic criteria for chronic GVHD (part I). Sci Rep. 2013;3:3419.","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1136\/bjo.83.10.1125","article-title":"Dry eye after haematopoietic stem cell transplantation","volume":"83","author":"Ogawa","year":"1999","unstructured":"9. Ogawa Y, Okamoto S, Wakui M, Watanabe R, Yamada M, Yoshino M, Ono M, Yang HY, Mashima Y, Oguchi Y, Ikeda Y, Tsubota K. Dry eye after haematopoietic stem cell transplantation. Br J Ophthalmol. 1999;83:1125-1130.","journal-title":"Br J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1167\/iovs.02-0699","article-title":"Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease","volume":"44","author":"Ogawa","year":"2003","unstructured":"10. Ogawa Y, Kuwana M, Yamazaki K, Mashima Y, Yamada M, Mori T, Okamoto S, Oguchi Y, Kawakami Y. Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease. Invest Ophthalmol Vis Sci. 2003;44:1888-1896.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/OPX.0000000000001071","article-title":"A review of ocular graft-versus-host disease","volume":"94","author":"SZ","year":"2017","unstructured":"11. Munir SZ, Aylward J. A review of ocular graft-versus-host disease. Optom Vis Sci. 2017;94:545-555.","journal-title":"Optom Vis Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1167\/iovs.05-0040","article-title":"Lacrimal gland involvement in graft-versus-host disease: a murine model","volume":"46","author":"Hassan","year":"2005","unstructured":"12. Hassan AS, Clouthier SG, Ferrera JL, Stepan A, Mian SI, Ahmad AZ, Elner VM. Lacrimal gland involvement in graft-versus-host disease: a murine model. Invest Ophthalmol Vis Sci. 2005;46:2692-2597.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1182\/blood-2009-03-208983","article-title":"Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD","volume":"114","author":"AC","year":"2009","unstructured":"13. Vigorito AC, Campregher PV, Storer BE, Carpenter PA, Moravec CK, Kiem HP, Fero ML, Warren EH, Lee SJ, Appelbaum FR, Martin PJ, Flowers ME; National Institutes of Health. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood. 2009;114:702-708.","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/ICU.0b013e32833eab64","article-title":"Current insights into ocular graft-versus-host disease","volume":"21","author":"Riemens","year":"2010","unstructured":"14. Riemens A, te Boome L, Imhof S, Kuball J, Rothova A. Current insights into ocular graft-versus-host disease. Curr Opin Ophthalmol. 2010;21:485-494.","journal-title":"Curr Opin Ophthalmol"},{"key":"ref14","unstructured":"15. Choi W, Ha JY, Li Y, Choi JH, Ji YS, Yoon KC. Comparison of the meibomian gland dysfunction in patients with chronic ocular graft-versus-host disease and Sj\u00f6gren's syndrome. Int J Ophthalmol. 2019;12:393-400."},{"key":"ref15","unstructured":"16. Ban Y, Ogawa Y, Ibrahim OM, Tatematsu Y, Kamoi M, Uchino M, Yaguchi S, Dogru M, Tsubota K. Morphologic evaluation of meibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy. Mol Vis. 2011;17:2533-2543."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jtos.2019.04.009","article-title":"Longitudinal analysis of meibomian gland dropout in patients with ocular graft-versus-host disease","volume":"17","author":"Hwang","year":"2019","unstructured":"17. Hwang HS, Ha M, Kim HS, Na KS. Longitudinal analysis of meibomian gland dropout in patients with ocular graft-versus-host disease. Ocul Surf. 2019;17:464-469.","journal-title":"Ocul Surf"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1001\/archopht.1989.01070020413046","article-title":"Conjunctival graft-vs-host disease","volume":"107","author":"Jabs","year":"1989","unstructured":"18. Jabs DA, Wingard J, Green WR, Farmer ER, Vogelsang G, Saral R. The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol. 1989;107:1343-1348.","journal-title":"Arch Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00417-019-04301-6","article-title":"Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle","volume":"257","author":"Giannaccare","year":"2019","unstructured":"19. Giannaccare G, Pellegrini M, Bernabei F, Scorcia V, Campos E. Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle. Graefes Arch Clin Exp Ophthalmol. 2019;257:1341-1351.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/08820538.2011.588663","article-title":"Keratoconjunctivitis sicca manifestations in ocular graft-versus-host disease: pathogenesis, presentation, prevention, and treatment","volume":"26","author":"Townley","year":"2011","unstructured":"20. Townley JR, Dana R, Jacobs DS. Keratoconjunctivitis sicca manifestations in ocular graft-versus-host disease: pathogenesis, presentation, prevention, and treatment. Semin Ophthalmol. 2011;26:251-260.","journal-title":"Semin Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.survophthal.2012.08.004","article-title":"Ocular graft-versus-host disease: a review","volume":"58","author":"Shikari","year":"2013","unstructured":"21. Shikari H, Antin JH, Dana R. Ocular graft-versus-host disease: a review. Surv Ophthalmol. 2013;58:233-251.","journal-title":"Surv Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/ICL.0000000000000150","article-title":"Ocular graft-versus-host disease: a review","volume":"41","author":"Balasubramaniam","year":"2015","unstructured":"22. Balasubramaniam SC, Raja H, Nau CB, Shen JF, Schornack MM. Ocular graft-versus-host disease: a review. Eye Contact Lens. 2015;41:256-261.","journal-title":"Eye Contact Lens"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1167\/iovs.16-20013","article-title":"In vivo confocal microscopy in dry eye disease associated with chronic graft-versus-host disease","volume":"57","author":"Kheirkah","year":"2016","unstructured":"23. Kheirkah A, Qazi Y, Arnoldner MA, Suri K, Dana R. In vivo confocal microscopy in dry eye disease associated with chronic graft-versus-host disease. Invest Ophthalmol Vis Sci. 2016;57:4686-4691.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41409-018-0340-0","article-title":"Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT","volume":"54","author":"Inamoto","year":"2019","unstructured":"24. Inamoto Y, Vald\u00e9s-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, Liu H, Rowley S, Schoemans H, Shah A, Lupo Stanghellini MT, Agrawal V, Ahmed I, Ali A, Bhatt N, Byrne M, Chhabra S, DeFilipp Z, Fahnehjelm K, Farhadfar N, Horn E, Lee C, Nathan S, Penack O, Prasad P, Rotz S, Rov\u00f3 A, Yared J, Pavletic S, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Petri\u010dek I. Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Bone Marrow Transplant. 2019;54:662-673.","journal-title":"Bone Marrow Transplant"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1167\/iovs.10-6997g","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction","volume":"52","author":"Geerling","year":"2011","unstructured":"25. Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T, Rolando M, Tsubota K, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2011;52:2050-2064.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Ogawa Y, Kuwana M. Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea. 2003;22:S19-S27.","DOI":"10.1097\/00003226-200310001-00004"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/bmt.2011.205","article-title":"Punctal occlusion is safe and efficient fort he treatment of keratoconjunctivitis sicca in patients with ocular GvHD","volume":"47","author":"Sabti","year":"2012","unstructured":"27. Sabti S, Halter JP, Braun Fr\u00e4nkl BC, Goldblum D. Punctal occlusion is safe and efficient fort he treatment of keratoconjunctivitis sicca in patients with ocular GvHD. Bone Marrow Transplant. 2012;47:981-984.","journal-title":"Bone Marrow Transplant"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/00003226-200009000-00009","article-title":"The diagnosis and management of dry eye: a twenty-five-year review","volume":"19","author":"Pflugfelder","year":"2000","unstructured":"28. Pflugfelder SC, Solomon A, Stern ME. The diagnosis and management of dry eye: a twenty-five-year review. Cornea. 2000;19:644-649.","journal-title":"Cornea"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1097\/01.ico.0000208813.17367.0c","article-title":"05% in the treatment of dry eye associated with graft versus host disease","volume":"25","author":"SN","year":"2006","unstructured":"29. Rao SN, Rao RD. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease. Cornea. 2006;25:674-678.","journal-title":"Cornea"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/01.ico.0000208818.47861.1d","article-title":"Ophthalmic cyclosporine use in ocular GVHD","volume":"25","author":"GJ Jr","year":"2006","unstructured":"30. Lelli GJ Jr, Musch DC, Gupta A, Farjo QA, Nairus TM, Mian SI. Ophthalmic cyclosporine use in ocular GVHD. Cornea. 2006;25:635-638.","journal-title":"Cornea"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1097\/ICO.0b013e3181e456f0","article-title":"05%","volume":"29","author":"Malta","year":"2010","unstructured":"31. Malta JB, Soong HK, Shtein RM, Musch DC, Rhoades W, Sugar A, Mian SI. Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%. Cornea. 2010;29:1392-1396.","journal-title":"Cornea"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.ophtha.2016.02.044","article-title":"A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease","volume":"123","author":"Abud","year":"2016","unstructured":"32. Abud TB, Amparo F, Saboo US, Di Zazzo A, Dohlman TH, Ciolino JB, Hamrah P, Dana R. A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease. Ophthalmology. 2016;123:1449-1457.","journal-title":"Ophthalmology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1136\/bjo.2004.044347","article-title":"Autologous serum eye drops for ocular surface disorders","volume":"88","author":"Geerling","year":"2004","unstructured":"33. Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. 2004;88:1467-1474.","journal-title":"Br J Ophthalmol"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Kojima T, Higuchi A, Goto E, Matsumoto Y, Dogru M, Tsubota K. Autologous serum eye drops for the treatment of dry eye diseases. Cornea. 2008;27 Suppl 1:S25-S30.","DOI":"10.1097\/ICO.0b013e31817f3a0e"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/sj.bmt.1702334","article-title":"GVHD dry eyes treated with autologous serum tears","volume":"25","author":"Rocha","year":"2000","unstructured":"35. Rocha EM, Pelegrino FS, de Paiva CS, Vigorito AC, de Souza CA. GVHD dry eyes treated with autologous serum tears. Bone Marrow Transplant. 2000;25:1101-1103.","journal-title":"Bone Marrow Transplant"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/sj.bmt.1703862","article-title":"Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease","volume":"31","author":"Ogawa","year":"2003","unstructured":"36. Ogawa Y, Okamoto S, Mori T, Yamada M, Mashima Y, Watanabe R, Kuwana M, Tsubota K, Ikeda Y, Oguchi Y. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant. 2003;31:579-583.","journal-title":"Bone Marrow Transplant"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/ICO.0b013e3180645cd7","article-title":"Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease","volume":"26","author":"Chiang","year":"2007","unstructured":"37. Chiang CC, Lin JM, Chen WL, Tsai YY. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Cornea. 2007;26:861-863.","journal-title":"Cornea"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1089\/jop.2012.0002","article-title":"Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease","volume":"28","author":"KS","year":"2012","unstructured":"38. Na KS, Kim MS. Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease. J Ocul Parmacol Ther. 2012;28:479-483.","journal-title":"J Ocul Parmacol Ther"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1097\/ICO.0b013e318155743d","article-title":"Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft versus host disease","volume":"26","author":"DS","year":"2007","unstructured":"39. Jacobs DS, Rosenthal P. Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft versus host disease. Cornea. 2007;26:1195-1199.","journal-title":"Cornea"}],"container-title":["Turkish Journal of Ophthalmology"],"original-title":[],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T13:02:16Z","timestamp":1721998936000},"score":1,"resource":{"primary":{"URL":"https:\/\/oftalmoloji.org\/articles\/doi\/tjo.galenos.2022.50945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,12,1]]},"published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.4274\/tjo.galenos.2022.50945","relation":{},"ISSN":["1300-0659","2147-2661"],"issn-type":[{"type":"print","value":"1300-0659"},{"type":"electronic","value":"2147-2661"}],"subject":[],"published":{"date-parts":[[2022,12,1]]}}}